Clover Health Investments (NASDAQ:CLOV) Trading Down 4.8% – Should You Sell?

Clover Health Investments, Corp. (NASDAQ:CLOV)’s stock price fell 4.8% during trading on Thursday . The company traded as low as $2.65 and last traded at $2.6750. 790,689 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 5,100,948 shares. The stock had previously closed at $2.81.

Key Clover Health Investments News

Here are the key news stories impacting Clover Health Investments this week:

• Positive Sentiment: Company-reported 53% year-over-year Medicare Advantage membership growth to ~153,000 members, driven by concentrated core-market expansion and strong retention; this is the primary operational driver behind recent buying interest. Clover Health Announces 53% Growth in Medicare Advantage Membership
• Positive Sentiment: Clover says it expects to achieve its first full-year GAAP net income profitability in 2026, citing improving cohort economics, SG&A leverage and favorable CMS/Part D payment factors — this guidance fueled the intraday surge reported by market outlets. Clover Health Investments (CLOV) Is Up 12.4% After Surging Medicare Advantage Growth And 2026 Profit Outlook – Has The Bull Case Changed?
• Positive Sentiment: High clinical rankings and tech edge: ~97% of membership is in its flagship PPO (ranked #1 on core HEDIS metrics) and Clover highlights Clover Assistant as a driver of clinical performance and cohort improvement. Quiver: Clover Health Reports 53% Medicare Advantage Membership Growth
• Neutral Sentiment: Valuation and analyst context: coverage pieces are recalculating valuation after the membership surge; recent median price targets remain modestly above current levels, leaving room for debate whether the rally fully prices in execution risk. A Look At Clover Health (CLOV) Valuation After Membership Surge And First Profit Outlook
• Neutral Sentiment: Peer/strategy comparisons: sector write-ups contrast Clover with other healthcare tech/MA players, useful for gauging relative growth and margin potential but not immediately market-moving by itself. Head to Head Contrast: Clover Health Investments (NASDAQ:CLOV) & CareCloud (NASDAQ:CCLD)
• Negative Sentiment: Execution and forward-looking risk: guidance is forward-looking and dependent on cohort improvement, CMS ratings, Part D subsidy and continued retention — investors may discount the outlook until full-year results are reported. Clover Health Investments Corp. (CLOV): A bull case theory
• Negative Sentiment: Ownership and liquidity dynamics: recent insider sales and mixed institutional flows raise the chance of short-term pressure and profit-taking after the AEP-driven rally. Quiver: Insider & Institutional Activity Summary

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CLOV shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Clover Health Investments in a research note on Monday, December 29th. Canaccord Genuity Group dropped their price objective on Clover Health Investments from $4.10 to $3.70 and set a “buy” rating on the stock in a research note on Thursday, November 6th. Leerink Partners set a $3.00 price objective on Clover Health Investments and gave the stock a “market perform” rating in a research report on Tuesday, October 21st. Zacks Research lowered Clover Health Investments from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. Finally, Wall Street Zen upgraded Clover Health Investments from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $3.23.

Clover Health Investments Trading Down 3.2%

The stock has a market cap of $1.41 billion, a P/E ratio of -24.77 and a beta of 2.12. The company’s fifty day simple moving average is $2.52 and its 200-day simple moving average is $2.77.

Clover Health Investments (NASDAQ:CLOV) last issued its earnings results on Tuesday, November 4th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.07). Clover Health Investments had a negative net margin of 3.29% and a negative return on equity of 16.79%. The business had revenue of $496.65 million for the quarter, compared to analyst estimates of $467.18 million. As a group, analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clover Health Investments

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC lifted its holdings in shares of Clover Health Investments by 95.7% during the second quarter. Geode Capital Management LLC now owns 9,843,349 shares of the company’s stock valued at $27,467,000 after acquiring an additional 4,812,368 shares during the period. Bank of America Corp DE boosted its position in Clover Health Investments by 217.5% in the second quarter. Bank of America Corp DE now owns 4,012,744 shares of the company’s stock valued at $11,196,000 after buying an additional 2,748,783 shares in the last quarter. Divisadero Street Capital Management LP bought a new stake in Clover Health Investments during the third quarter worth about $8,470,000. UBS Group AG increased its holdings in shares of Clover Health Investments by 155.5% during the third quarter. UBS Group AG now owns 2,282,113 shares of the company’s stock worth $6,983,000 after buying an additional 1,388,761 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Clover Health Investments by 199.4% in the third quarter. Dimensional Fund Advisors LP now owns 2,140,282 shares of the company’s stock valued at $6,551,000 after acquiring an additional 1,425,391 shares during the last quarter. Institutional investors own 19.77% of the company’s stock.

About Clover Health Investments

Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.

At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.